Treating Multiple Sclerosis
Cylenta Pharmaceuticals is a participant in New Mexico Start-Up Factory's L2B 2016 accelerator.
Cylenta Pharmaceuticals is a multiple sclerosis pharmaceutical research company that is developing lab-made compositions for the treatment and prevention of a wide-variety of ischemia-related injuries.
Technologist Jeff Hill, PhD is a Research Asst Professor: SOM Neurosurgery and has been awarded a number of grants for this research, including funding from the National Multiple Sclerosis Society. His research in animal models is on-going at the University of New Mexico's Health Sciences Center.